{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&_metadata=all&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "items" : [{"_about" : "http://data.parliament.uk/resources/1137390", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137390/answer", "answerText" : {"_value" : "<p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.<\/p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department\u2019s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement\u2019s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL16998"}
        , {"_value" : "HL16999"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:23:54.303Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lumacaftor/ivacaftor"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether a date has been set for Vertex pharmaceuticals, NICE and NHS England to convene a further meeting to discuss how the cystic fibrosis drug Orkambi can be made available to patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2168", "label" : {"_value" : "Biography information for Baroness Morgan of Huyton"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Morgan of Huyton"}
      ], "uin" : "HL16997"}
    , {"_about" : "http://data.parliament.uk/resources/1137391", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137391/answer", "answerText" : {"_value" : "<p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.<\/p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department\u2019s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement\u2019s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL16997"}
        , {"_value" : "HL16999"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:23:54.243Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lumacaftor/ivacaftor"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the impact of the lack of availability of Orkambi on patients with cystic fibrosis; and what plans they have to discuss this issue with (1) patients, and (2) other interested parties.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2168", "label" : {"_value" : "Biography information for Baroness Morgan of Huyton"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Morgan of Huyton"}
      ], "uin" : "HL16998"}
    , {"_about" : "http://data.parliament.uk/resources/1137392", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137392/answer", "answerText" : {"_value" : "<p>NHS England and NHS Improvement is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi and Symkevi in advance of a positive assessment by the National Institute for Health and Care Excellence (NICE), in addition to expanded access to Kalydeco which is already funded by the National Health Service for certain patients. No date has been agreed for a further meeting as of yet, however negotiations are ongoing between Vertex, NHS England and NHS Improvement and NICE.<\/p><p>Cystic fibrosis can have a devastating effect on the lives of those who suffer from it, and those close to them, and the Government wants to see patients access innovative treatments at a cost-effective price for the NHS. The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department\u2019s approach remains to strongly urge Vertex to accept NHS England and NHS Improvement\u2019s generous offer, but in the absence of a deal, we have asked NHS England and NHS Improvement to continue to explore all options to ensure patients can access treatments as soon as possible.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL16997"}
        , {"_value" : "HL16998"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:23:54.35Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Lumacaftor/ivacaftor"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what plans the Secretary of State for Health and Social Care has to intervene in the ongoing negotiations between Vertex pharmaceuticals, NICE and NHS England on the price of the cystic fibrosis drug Orkambi to ensure that it is made available to patients as soon as possible.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2168", "label" : {"_value" : "Biography information for Baroness Morgan of Huyton"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Morgan of Huyton"}
      ], "uin" : "HL16999"}
    , {"_about" : "http://data.parliament.uk/resources/1137092", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137092/answer", "answerText" : {"_value" : "<p>The Department has made no formal assessment of the finding of the House of Commons Health Committee in its report NHS Charges (HC815\u20131), published on 18 July 2006, that the list of exemptions for prescription charges was \u201cinconsistent and anomalous\u201d. The Department has no current plans to review the existing National Health Service prescription charging exemption arrangements.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T11:04:01.967Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the answer by Baroness Blackwood of North Oxford on 3 July (HL Deb, col 1435), what assessment they have made of the finding of the House of Commons Health Committee in its report NHS Charges (HC815\u20131), published on 18 July 2006, that the list of exemptions for prescription charges was \u201cinconsistent and anomalous\u201d; and what plans they have, in any future meetings with Asthma UK, to discuss the current list of exemptions for prescription charges in regard to those who have asthma.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16956"}
    , {"_about" : "http://data.parliament.uk/resources/1137093", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137093/answer", "answerText" : {"_value" : "<p>We have received a number of representations from Parliamentarians, stakeholders, individuals and other interested parties on prescription exemptions for people with long term health conditions. Whether any specific health condition was mentioned in each such representation is not recorded centrally and to obtain this information would incur disproportionate cost. Furthermore, the Department has made no estimate of the number of people in England that are subject to prescription exemptions for such conditions. However, around 89% of National Health Service prescription items are dispensed in the community free of charge.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:26:15.303Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what representations they have received about prescription charges for people with lifetime health conditions in the last two years; whether they record the health conditions each such representation related to; and how many people in England they estimate are subject to prescription charges for such conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16957"}
    , {"_about" : "http://data.parliament.uk/resources/1137094", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137094/answer", "answerText" : {"_value" : "<p>The Department has made no such estimate. Extensive arrangements are already in place to help people access National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions.<\/p><p>To support those with greatest need who do not qualify for an exemption, cost of the prescription pre-payment certificates were frozen for another year. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:26:36.47Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what estimate they have made, if any, of the annual cost to the NHS of providing free prescriptions to those with (1) asthma, and (2) long-term health conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16958"}
    , {"_about" : "http://data.parliament.uk/resources/1137095", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137095/answer", "answerText" : {"_value" : "<p>NHS England and NHS Improvement do not collect any payment for free prescriptions.<\/p><p>The costs to administer the system of medical exemption certificates is around £1 million. The costs to provide prescription prepayment certificates is around £4.8 million. These figures have been provided by the NHS Business Services Authority and are for the financial period 2018/19.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T11:02:36.027Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government how much it costs NHS England annually to (1) collect payments for free prescriptions, (2) administer the system of medical exemption certificates, and (3) provide prescription prepayment certificates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16959"}
    , {"_about" : "http://data.parliament.uk/resources/1137096", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137096/answer", "answerText" : {"_value" : "<p>The Department has made no such assessment. All issues relating to healthcare provision are a matter for the devolved administrations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:49:05.263Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of any savings made by the NHS in Scotland, Wales and Northern Ireland as a result of not charging for prescriptions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16960"}
    , {"_about" : "http://data.parliament.uk/resources/1137097", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137097/answer", "answerText" : {"_value" : "<p>The Department has made no such estimate. Extensive arrangements are already in place to help people access National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions, for which someone with asthma and other long-term health conditions may qualify.<\/p><p>To support those with greatest need who do not qualify for an exemption, cost of the prescription pre-payment certificates were frozen for another year. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:54:56.927Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what estimate they have made of the annual cost to NHS England of GP appointments and hospital admissions arising from people with asthma and other long-term health conditions who do not take prescription medications because they cannot afford them.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2484", "label" : {"_value" : "Biography information for Lord Rennard"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Rennard"}
      ], "uin" : "HL16961"}
    , {"_about" : "http://data.parliament.uk/resources/1136783", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1136783/answer", "answerText" : {"_value" : "<p>Following, a new, open competition, the Government has recently announced National Institute of Health Research (NIHR) designation and funding for 15 Applied Research Collaborations (ARCs), with total funding of £135 million over five years from 1 October 2019.<\/p><p>Each NIHR ARC will have its own local governance arrangements in place, with the named Director of each NIHR ARC having responsibility, and authority over, the NIHR funding awarded to their National Health Service organisations through the scheme. Under the terms of the NIHR contract, the NIHR ARCs will be required to submit annual progress reports and can be subject site visits to evaluate progress, performance and identify key issues.<\/p><p>All NIHR ARCs are required to ensure that research is conducted in accordance with the United Kingdom Policy Framework for Health and Social Care Research and the Concordat to Support Research Integrity and the Governance Arrangements for Research Ethics Committees.<\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-07-15T10:25:42.427Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-07-03", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medicine: Research"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what governance arrangements they have proposed for the newly designated Academic Research Collaborations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4151", "label" : {"_value" : "Biography information for Lord Willis of Knaresborough"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Willis of Knaresborough"}
      ], "uin" : "HL16933"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answer.dateOfAnswer=2019-07-15&min-answer.questionFirstAnswered.=2019-05-15T12%3A39%3A20.147Z&answer.answeringMember.label=Biography+information+for+Baroness+Blackwood+of+North+Oxford", "page" : 0, "startIndex" : 1, "totalResults" : 19, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}